Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-037802
Filing Date
2021-09-27
Accepted
2021-09-27 17:22:04
Documents
1
Period of Report
2021-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3701
  Complete submission text file 0000899243-21-037802.txt   5055
Mailing Address C/O MAGENTA THERAPEUTICS 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address
ZDRAVESKI ZORAN (Reporting) CIK: 0001741285 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40603 | Film No.: 211282784

Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Issuer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)